Bristol Myers Squibb Co (BMY) stock
BMYNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as CELG.RI
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 15/3031% below fair value
$58.80+0.46 (+0.79%)
Close on Nov 20, 2026Market cap $120.19BP/E 13.0Yield 4.23%
Bristol Myers Squibb operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
No operating income figures for Bristol Myers Squibb
Bristol Myers Squibb has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?